Hope for advanced head & neck cancer patients

Researchers at Ben-Gurion University have developed an innovative treatment for Head & Neck Cancer (HNC) sufferers. It blocks the hyper-activation of a specific cell-signaling pathway that is found in over 40% of HNC patients.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *